Dual antigen anthrax vaccine (LigoCyte)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDual antigen anthrax vaccine (LigoCyte)

Drug Alias NameMucosal anthrax vaccine - LigoCyte PharmaceuticalsIntranasal, dry powder anthrax vaccine - LigoCyte Pharmaceuticalsbiodefence vaccines and therapeutics - Ligocyte PharmaceuticalsBiodefense vaccines and therapeutics - Ligocyte PharmaceuticalsAnthrax vaccines - LigoCyte Pharmaceuticals +[8]

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsAnthrax

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesLigocyte

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLigocyte

Active IndicationsN/A

Inactive IndicationsAnthrax

Other Information

ATC CodeN/A